Best Startup
At Best Startup UK we track over 130,000 UK startups and over 500,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top United Kingdom based Founder operating in the Medical Device space. If you think a Founder is missing from this list, feel free to contact our editor on editor@beststartup.co.uk.
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Companies House UK, Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Chris Hancock
CTO & Founder of Creo Medical
Chris has over fifteen years experience creating and developing new medical device IP focused on the use of microwave and RF energy for therapeutic applications. In 2002 he founded MicroOncology Ltd (renamed Creo Medical Ltd in 2009) to develop his ideas relating to new cancer treatment systems using state of the art semiconductor device technology to generate high frequency microwave and millimetre wave energy, and novel energy delivery and measurement techniques to identify and controllably ablate cancerous tissue. He is currently the CTO and founder of Creo Medical Ltd and holds a personal Chair in the Medical Microwave Systems Research Group at Bangor University. Chris is a Fellow of the Institute of Physics, a Chartered Physicist , Fellow of the Institute of Engineering and Technology, a Chartered Engineer and a Senior Member of the IEEE. He is a named inventor and lead author on over 100 patents/patent applications and journal publications.
Follow Chris Hancock:
About Creo Medical, Institute of Physics: Creo Medical is a developer of electrosurgical devices.
Luke Heron
Co-Founder of TestCard Ltd
Luke Heron co-founded TestCard.com, a UK domiciled startup revolutionising the direct to consumer healthcare diagnostics market.
Follow Luke Heron:
About TestCard Ltd: TestCard is the medical technology company behind the eponymous at-home test kit. A partnering mobile app delivers immediate results.
Dr Andrew Botham
Co-Founder and CSO of TestCard Ltd
Follow Dr Andrew Botham:
About TestCard Ltd: TestCard is the medical technology company behind the eponymous at-home test kit. A partnering mobile app delivers immediate results.
Houman Ashrafian
Managing Partner & Founder of SV Health Investors
Houman Ashrafian is the Managing Partner at SV Health Investors.
Follow Houman Ashrafian:
About Catamaran Bio, Cellinta, Enara Bio, Karus Therapeutics, Sitryx Therapeutics, SV Health Investors, Zarodex Therapeutics: SV Health Investors is a Boston-based venture capital firm focused on investments in biotechnology and healthcare industry.
Stewart Whiting
Tech Co-Founder & CTO of Current Health
Follow Stewart Whiting:
About Current Health: We help healthcare reduce risk & cost by monitoring, managing and engaging patients at home.
Emil Hewage
Co-Founder & CEO of BIOS
Emil’s academic background is as a PhD researcher in computational neuroscience and machine learning. He brings knowledge of neural signalling and signal processing with over 7 year’s industrial & academic R&D experience. He has previously developed medical devices with Siemens Healthcare and Sphere Medical as well as having held roles in finance and medical and cleantech startups.
Follow Emil Hewage:
About BIOS: A full-stack neural interface platform, that uses AI to decode and encode the signals from to the body, to treat chronic health conditions.
Oliver Armitage
Co-Founder & CSO of BIOS
Oliver Armitage is Co-Founder and Chief Scientific Officer at BIOS, a leading neural engineering startup. Oliver has always had a vision that the human body could be repaired or made better through augmentative technology and how that can be used to improve people’s lives. He studied for his PhD at the University of Cambridge in Bioengineering, working in the world-renowned Nanoscience Centre. He specializes in tissue interfaces and engineering to allow technology to be fused with the body. Oliver was recently named to Forbes 30 Under 30 2018.
Follow Oliver Armitage:
About BIOS: A full-stack neural interface platform, that uses AI to decode and encode the signals from to the body, to treat chronic health conditions.
Nader Alaghband
Co-Founder & CEO of Ampersand Health
Follow Nader Alaghband:
About Ampersand Health: Ampersand creates innovative digital medicines for complex long term conditions, using behavioural and data-science.
John E. Milad
CEO & Founder of Quanta
John E. Milad is a global healthcare executive, board member, investor, speaker and author. He has a career spanning over 25 years, with experience working in various senior positions in the healthcare sector, including NBGI Ventures, Atlas Venture, Nitec Pharma and Nomura. Currently, John is Chief Executive Officer and founding board member at Quanta Dialysis Technologies, where he recently raised $245m in Series D funding. An executive with international experience in building and growing successful healthcare companies, John had the vision and belief that core technology of managing fluidics on a disposable cartridge could be developed into a portable hemodialysis device with the potential to address multiple unmet needs in the $93 billion global dialysis market. John is a regular speaker and panelist at global medtech and investment conferences and has co-authored 4 peer-reviewed papers.
Follow John E. Milad:
About NBGI Ventures, Quanta: Quanta develops an advanced haemodialysis systems for use in the home and clinic.
Ali Rezaei Haddad
CEO and Founder of NeuroNav
Ali is a neurosurgical resident in London and an NHS Clinical Entrepreneur. Prior to this, he completed his Academic Foundation Training in the Medical Sciences Division at the University of Oxford undertaking research in the field of neuroimaging. He graduated with first class honours in Neurosciences BSc at Imperial College London, and he holds honorary research positions at the University of Oxford and St George’s Medical School. Ali co-founded the internationally acclaimed GoodSAM app used by the NHS, in which clinically trained individuals sign up as volunteers to respond to life-threatening emergency calls. He also directed and curated the Imagining the Future of Medicine at the Royal Albert Hall in partnership with TEDMED, attended by a live audience of 5,000 people. Inspired by the lack of user friendly and affordable neuronavigation solutions worldwide, he founded NeuroNav to democratise access to neurosurgery navigation solutions.
Follow Ali Rezaei Haddad:
About Imperial College Healthcare NHS Trust, NeuroNav: An augmented reality neuronavigation platform powered by computer vision and machine learning.
Seyed-Mahdi Khaligh-Razavi
Co-Founder and Chief Science Officer of Cognetivity Neurosciences
Seyed-Mahdi Khaligh-Razavi is the Co-Founder and Chief Science Officer at Cognetivity Neurosciences.
Follow Seyed-Mahdi Khaligh-Razavi:
About Cognetivity Neurosciences: Cognetivity Neurosciences is a Platform technology for early, rapid and easy detection of dementia.
Carina Cunha
Co-Founder & CEO of Be Nosy
Carina is a business strategist and inventor of Nosy with passion for science, sales and marketing. In her former role as MD and Launcher of Crimson Education Europe, she created sales, marketing and service delivery teams from scratch, achieving millions in ARR and 150%+ YoY growth. Prior to working with startups Carina was corporate strategist at JPMorgan, Strategy Consultant at Accenture, Investment Banker at Credit Suisse, and a fashion model with Elite. Carina is also an innovation and commercial consultant through Meta Strategy and Founders Intelligence where she helps startups and scale-ups find product-market fit and corporates build new revenue lines. She has a B.A. from Columbia University and PgD. from the University of Edinburgh.
Follow Carina Cunha:
About Be Nosy: Nosy is a MedTech startup developing wearable air filter and air pollution tracking network.
David Tuch
Founder & Executive Chairman of Lightpoint Medical
David Tuch is the Founder and CEO of Lightpoint Medical. He has more than a decade of experience in the medical imaging and pharmaceutical sectors. Previously, he was Head of Research Alliances at GE Healthcare and Head of Clinical Imaging at Novartis. Before joining industry, Dr. Tuch served on the faculty of Harvard Medical School and Massachusetts General Hospital, Department of Radiology. He is currently an Honorary Senior Lecturer in the Imperial College, Department of Bioengineering. Dr. Tuch holds a PhD from MIT and Harvard Medical School, a BA from the University of Chicago, and has completed executive education at INSEAD.
Follow David Tuch:
About Lightpoint Medical, Lucida Medical: Lightpoint Medical, a medical device company, develops intra-operative imaging technology that can detect cancer during surgery.
Sophie Dundovic
Co-Founder of Parasym
Sophie Dundovic is a Co-founder at Parasym.
Follow Sophie Dundovic:
About Parasym: Parasym is a neurotechnology company focused on providing innovative neurostimulation products that improve quality of life.
Mosin Badkar
Co-Founder and VP of Cardiac Design Labs
Mosin Badkar is responsible for product R and D and Algorithms. His scope includes design of new products, prototyping of design and proof of concept. His scope also includes planning and tracking of new product designs, system level and various software development activities.
Follow Mosin Badkar:
About Cardiac Design Labs: Cardiac Design Labs is into designing, developing, deploying and selling intelligent devices for medical purpose.
Tess Cosad
Co-Founder & CEO of Bea Fertility
Tess Isabelle Cosad is the Chief Executive Officer and Co-Founder of Bea Fertility.
Follow Tess Cosad:
About Bea Fertility: Bea Fertility is a monthly subscription program that provides users with at-home fertility treatment and ovulation tracking.
David O’Rourke
Co-Founder and Chief Scientific Officer (CSO) & Chief Innovation Officer (CIO) of Bea Fertility
David O’Rourke is the Chief Operating Officer and Co-Founder of Bea Fertility.
Follow David O’Rourke:
About Bea Fertility, Vitrolife: Bea Fertility is a monthly subscription program that provides users with at-home fertility treatment and ovulation tracking.
Richard Vincent
CEO & Co-Founder of FundamentalVR
Richard has 20+ years’ experience of building international businesses and has throughout his career sought opportunities for positive market disruption through technological application. It was this desire that led him to co-found FundamentalVR to help address an age-old problem for the medical market; how to create safe, realistic, measurable spaces to learn and develop skills. In his role as CEO Richard is responsible for building a world class team of medical, learning and technologist who together can realise the company’s ambition of creating the world’s first global, haptically enabled, low cost ‘flight simulator for surgeons’.
Follow Richard Vincent:
About Fundamental Surgery, FundamentalVR: FundamentalVR delivers VR haptic ‘flight simulators’ for surgery creating a safe, measurable & repeatable space to refine to refine skills.
Chris Scattergood
CRO & Founder of FundamentalVR
A key part of his role at Fundamental, Chris visits leading surgeons, educators, hospital groups, bodies and device manufacturers across the US to understand their educational needs and requirements for successful integration into our learning platform, and continue to develop our product to support those needs. As one of the co-founders of Fundamental, in 2014 Chris and his co founder saw the opportunity to invest in Virtual Reality as the next tech platform after mobile to revolutionise the way we communicate, share and learn together. From his experience in the Healthcare sector, it was clear that VR presented a clear opportunity to make a real difference in way education could be delivered for Health care professionals.
Follow Chris Scattergood:
About Fundamental Surgery, FundamentalVR: FundamentalVR delivers VR haptic ‘flight simulators’ for surgery creating a safe, measurable & repeatable space to refine to refine skills.
Brian Falzon
Founder of Veryan Medical
Brian G. Falzon is the Head of the School of Mechanical and Aerospace Engineering, and Professor of Composite Materials and Aerostructures at Queen’s University Belfast. Between 2013 and 2017, he held the prestigious Royal Academy of Engineering – Bombardier Chair in Aerospace Composites. Between 2008 and 2012 he was the Foundation Chair in Aerospace Engineering at Monash University in Melbourne, Australia, where he was also Director of Research and Head of the Aerospace Engineering programmes. Between 1996 and 2008, Professor Falzon was at Imperial College London where he joined as a postdoctoral research fellow before becoming an academic staff member. Professor Falzon graduated with a PhD in Aeronautical Engineering from the University of Sydney in 1996 and was awarded the Golden Jubilee graduate prize for his research into postbuckling composite aerostructures. He also gained a Master of Engineering in Aeronautical Engineering with first class honours and a Bachelor of Science with a double major in Physics and Pure Mathematics from the same University. He is a Fellow of the Royal Aeronautical Society Professor Falzon is internationally renowned for his work on the analysis, design, manufacture and testing of advanced composite aerostructures and has published over 120 peer reviewed journal and conference papers in this area. He has fostered extensive industry and academic collaborations with partners from Europe, Australia, India and China. In 2008 Professor Falzon was awarded the George Taylor Prize by the Royal Aeronautical Society for the best paper published in 2007 in the design, construction, production and fabrication of aircraft structures. In 2009 he was honoured with an Australian Leadership Award, from the Australian Davos Connection, in recognition of his contribution to issues of national importance and demonstrated leadership in his field. In 2016 he was the recipient of Queen’s University Belfast’s Postgraduate Supervisory Excellence Award. He is a Chartered Engineer and a member of a number of professional organisations and scientific committees. Between 2006 and 2009 he was a member of the UK’s EPSRC Peer Review College and in 2010 and 2012 he was selected to serve on the Research Evaluation Committee panel for the Australian Research Council’s Excellence in Research for Australia exercise which is equivalent to the UK’s Research Excellence Framework (REF). Professor Falzon is also co-founder of Veryan Medical Limited, a company spin-off from Imperial College London.
Follow Brian Falzon:
About Queen’s University Belfast, Veryan Medical: Veryan Holdings is a medical device company developing three dimensional vascular stents for peripheral vascular disease.
Michalis Papadakis
CEO & Co-Founder of Brainomix
Dr Michalis Papadakis is the CEO and co-founder of Brainomix. He leads the management team, commercial strategy, fund raising, and corporate partnerships. He has grown the company from the ground up, building the company’s global presence and has raised over £15 million of private investment and public funding. When he founded Brainomix he was the Scientific Director of the preclinical stroke lab at the University of Oxford. He has a BSc Honours in Biochemistry from Imperial College London and a PhD in neurosciences from UCL School of Pharmacy. He has been an invited speaker at international scientific and innovation conferences
Follow Michalis Papadakis:
About Brainomix: Brainomix specializes in the creation of AI-powered imaging biomarkers that enable precision medicine for better treatment decisions
Eoin McKinney
Chief Scientific Officer & Co-Founder of PredictImmune
Eoin is a Wellcome-Beit intermediate Research Fellow in the Department of Medicine at the University of Cambridge and an honorary consultant in nephrology and transplantation in Cambridge University NHS hospitals Foundation Trust. He obtained a first-class degree in pre-clinical medicine from Keble College, Oxford University in 1999 and graduated in clinical medicine with honours from Edinburgh University in 2002. His primary interest is the use of systems immunology approaches to translate high throughput analyses of autoimmune disease datasets into clinical practice.
Follow Eoin McKinney:
About PredictImmune: Providing tools to physicians in the treatment of patients with immune-mediated disease, through prediction of long term clinical prognosis.
Kenneth Smith
Co-Founder & Chief Medical Officer of PredictImmune
Professor Ken Smith is Professor of Medicine and Head of the Department of Medicine at the University of Cambridge. He trained in nephrology (FRACP, FRCP) and clinical immunology (FRCPA) and completed a PhD at the WEHI in Melbourne. His laboratory runs a translational programme in autoimmune disease (particularly inflammatory bowel disease, vasculitis and SLE) that has led to the discovery of a novel prognosis-predicting biomarker currently in clinical trials and the identification of genes and pathways involved in disease pathogenesis.
Follow Kenneth Smith:
About PredictImmune: Providing tools to physicians in the treatment of patients with immune-mediated disease, through prediction of long term clinical prognosis.
Paul Lyons
Vice President of Platform Delivery & Co-Founder of PredictImmune
Paul is a Principal Research Associate in the Department of Medicine at the University of Cambridge. He has over 25 years of experience in molecular and cellular biology including Senior Scientist positions in the Dept. Medical Genetics, University of Cambridge, Dept. Surgery, University of Oxford and the Rosalind Franklin Centre for Genomics Research. His primary research interest is the application of high throughput genomic approaches to better understand the genetic and molecular basis of autoimmune disease.
Follow Paul Lyons:
About PredictImmune: Providing tools to physicians in the treatment of patients with immune-mediated disease, through prediction of long term clinical prognosis.
Ali Moiyed
CEO & Founder of Aerobit Health
Follow Ali Moiyed:
About Aerobit Health: Breathing New Life Into Asthma Care
Krishan Ramdoo
CEO and Founder of Tympa Health Technologies LTD
Krishan Ramdoo is the CEO and Founder of TympaHealth Technologies.
Follow Krishan Ramdoo:
About Tympa Health Technologies LTD: TympaHealth are a team of doctors and technology experts united in their vision of helping the world to hear.
Alex Hooi
Chief Medical Officer / Founder of Callaly
Inventor of the Tampliner®, and a co-founder at Callaly.He is also an NHS Gynaecologist, Consultant Specialist and Clinical Director of the Barking Havering and Redbridge University Hospitals NHS Trust and Fellow of the Royal College of Obstetricians and Gynaecologists.
Follow Alex Hooi:
About Callaly: Callaly is a period care company that develops and manufactures innovative feminine care products.
Thang Vo-Ta
CEO & Co-Founder of Callaly
Co-founder & CEO at Callaly.Thang is a graduate of MIT and started his career in Goldman Sachs in NYC & London.
Follow Thang Vo-Ta:
About Callaly: Callaly is a period care company that develops and manufactures innovative feminine care products.
Agnieszka Chomka
Co-Founder and Head of R&D of BioMe Oxford
Agnieszka is an intestinal immunologist at the Kennedy Institute for Rheumatology, University of Oxford. Her main research interests focus on the microbial-host interactions in the large intestine. She was awarded the prestigious Wellcome Trust scholarship at the University of Oxford to conduct her research into the role of a tissue-resident regulatory immune cell population in the gut. Agnieszka has published her results in top peer-review research journals.
Follow Agnieszka Chomka:
About BioMe Oxford, Globe Life Sciences: Unlocking your gut microbiome by developing a medical device for targeted and non-invasive sampling
Soren Krogsgaard Thomsen
Co-Founder, CEO and Managing Director of BioMe Oxford
Soren is a medical scientist at the University of Oxford, with a background in the natural sciences and genetics research. He previously worked as a consultant for pharma and OBR consulting, and has published on his experiences as an academic entrepreneur. Soren’s current research is focused on translating large-scale genetic data into mechanisms for disease to inform new therapeutic strategies. He dreams of one day enabling similar population-wide microbiome studies using the platform technology under development at BioMe Oxford Ltd.
Follow Soren Krogsgaard Thomsen:
About BioMe Oxford, Vertex Pharmaceuticals: Unlocking your gut microbiome by developing a medical device for targeted and non-invasive sampling
Patrick Albers
Co-Founder and Head of Technology of BioMe Oxford
Follow Patrick Albers:
About BioMe Oxford, Wellcome Trust Sanger Institute: Unlocking your gut microbiome by developing a medical device for targeted and non-invasive sampling
Samantha Payne
Co Founder & COO of Open Bionics
Samantha Payne is the co founder of Open Bionics; a robotics company developing assistive devices that enhance the human body. The company has won multiple awards for Engineering and Innovation including two British Engineering Excellence Awards and the James Dyson award for innovative design. Open Bionics works with companies like Disney to children with limb differences into bionic superheroes. They were the first company to bring affordable multi-grip bionic hands to the National Health Service in the UK.
Follow Samantha Payne:
About Open Bionics: Open Bionics is a robotics company creating affordable 3D-printed bionic hands for amputees, researchers and makers.
Ioannis Papakonstantinou
Founder of Echopoint Medical
Ioannis holds a PhD in Optical Interconnections from University College London. After his PhD, he joined Sharp Laboratories of Europe to work on the design and fabrication of photonic nanostructures for Optical Displays. Subsequently, he joined CERN-European Organisation of Nuclear Research where he led the work on fibre optic communication systems for particle physics detectors. He is currently a Professor of Photonics and Nanofabrication in the Department of Electronic and Electrical Engineering at UCL where he leads the Photonic Innovations Lab (www.ee.ucl.ac.uk/pilab). The mission of his lab is to exploit the synergies between nanotechnology and photonics for energy and biomedical applications. Ioannis has authored/co-authored over 130 journal publications and conference proceedings and is the holder of over 10 patent families.
Follow Ioannis Papakonstantinou:
About Echopoint Medical: Echopoint Medical is a medtech company
Richard Colchester
Founder of Echopoint Medical
Richard was born in Ipswich, U.K., in 1990. He received the MSci degree in physics from Imperial College London, London, U.K., in 2012, and the MRes degree in photonic systems development from University College London, London, U.K., in 2013. He finished his Ph.D. in Medical Physics and Biomedical Engineering at University College London in 2016. On completion of his Ph.D. he was award an EPSRC Doctoral Prize Fellow at University College London to develop an all-optical ultrasound imaging system for cardiovascular procedures. Since, he has received a Royal Academy of Engineering research fellowship to continue his work in this field and establish his research. His research interests include developing interventional medical imaging systems based on laser-generated ultrasound and photoacoustics.
Follow Richard Colchester:
About Echopoint Medical: Echopoint Medical is a medtech company
Katerina Spranger
Founder and CEO of Oxford Heartbeat
Katerina is the Fellow of the Royal Academy of Engineering. She holds a PhD in Biomedical Engineering from the University of Oxford and was previously a researcher in AI at the Sony Computer Science Laboratory in Paris.
Follow Katerina Spranger:
About Oxford Heartbeat, Royal Academy of Engineering: Oxford Heartbeat makes cardiovascular surgery more accurate and safe.
Julian Shapley
Chief Scientific Officer and Founder of CellNovo
Dr. Shapley has a cross-functional engineering and scientific background, specialising in Microsystems for drug discovery. Dr Shapley worked with the International Space School at NASA in Houston, Texas. He is also the inventor of Cellnovo’s unique pump technology which serves as the cornerstone of the Cellnovo Mobile Diabetes Management System.
Follow Julian Shapley:
About CellNovo: CellNovo is a medical device company developing a wireless therapeutic system for diabetic patients.
Ema Kufel
Co-Founder, CEO of Prosoma
Co-Founder/CEO, Ema is an (MSc) Marketing Communications graduate and an expert in healthcare communications. Ema has vast experience in managing projects developing digital strategies within the National Health Service and the Department of Health in the UK. She is passionate about healthcare and innovation, key components of Prosoma.
Follow Ema Kufel:
About Prosoma: At Prosoma, we design world-leading digital therapeutics solutions for Oncology.
Marek Ostrowski
Founder of Prosoma
Founder, Marek finished Philosophy at the University of Wrocław, and then a post-graduate accredited Psychotherapy course, and Simonton’s Therapy Course. He specialises in working with oncological patients. From 2008, the founder and shareholder of a tech company, in which he was responsible for the development, innovation and management of strategic projects.
Follow Marek Ostrowski:
About Prosoma: At Prosoma, we design world-leading digital therapeutics solutions for Oncology.
Ronan Cunningham
Founder and Chief Executive Officer of BrainWaveBank
Ronan has more than 20 years of experience in advanced engineering and product development. He was one of the founding members of ATA Engineering, an award-winning San Diego-based engineering company specializing in development of innovative hardware and software technologies for the aerospace and defence industries. His roles have included Director of Business Development and Director of New Technology Development. He is an Entrepreneur-in-Residence with the Northern Ireland Science Park. His expertise is in early stage technology development, innovation strategy, and technology commercialisation. He holds an MS in Aeronautics and Astronautics from MIT.
Follow Ronan Cunningham:
About BrainWaveBank, Cumulus Neuroscience: BrainWaveBank makes it possible to measure and track brain activity and cognitive performance for anyone, anytime, anywhere.
Alexandra Hussenot
Founder & CEO of Immersionn
Alexandra is the founder of Immersionn, the world’s first VR Discovery Engine and she is also the UK lead for ‘Women in Immersive Technologies’, a community of 1000 members that aims to empower European women working in XR. She is also 1 in 10 members of the UK5G Creative Industries working group reporting the department in charge of Digital, Medias, Culture and Sport (DCMS). Prior to this, Alexandra pursued an international business career at insurance firm, Allianz, managing an £80M global business. She has also worked all over Europe during her 11 years at Sony Ericsson (now Sony Mobile) and has solid experience designing and launching software and service products, particularly covering user experience design and continuous improvements. She also lead large scale operations for mobile phone repairs and remanufacturing.
Follow Alexandra Hussenot:
About Immersionn: Immersionn is a content discovery company. We allow people to discover VR content they would never find
Constantin Coussios
Founder & Chief Scientific Officer of OxSonics Therapeutics
Professor Constantin holds BA, MEng, MA and PhD degrees in Engineering from the University of Cambridge, and was elected to the first statutory chair in Biomedical Engineering at the University of Oxford in 2011, where he serves as the Director of the Institute of Biomedical Engineering. He is the author of over 100 peer-reviewed publications and 16 patents in the fields of drug delivery, acoustic cavitation and therapeutic ultrasound. Prof. Coussios received the UK’s Institute of Acoustics’ Young Person’s Award for Innovation in Acoustical Engineering in 2007, was elected as Secretary-General of the International Society for Therapeutic Ultrasound between 2006-2010 and was honoured with the Society’s Fred Lizzi award in 2012. He was elected as the youngest ever Fellow of the Acoustical Society of America in 2009 for contributions to biomedical ultrasound, and received the Society’s Bruce Lindsay award in 2012. Prof. Coussios leads the company’s technical development programmes.
Follow Constantin Coussios:
About OrganOx, OrthoSon, OxSonics Therapeutics, University of Oxford: OxSonics® Therapeutics’ proprietary drug delivery platform technology, SonoTran®
Colin Story
Co-Founder & CEO of OxSonics Therapeutics
Colin Story brings over 20 years of medical technology and life sciences industrial experience, the majority held in commercial roles. After graduating with a BSc degree in Biological Sciences and a PhD in Molecular Biology he started his career at Amersham plc (now GE Healthcare) in 1997. Initially he held Product Development and Project Management roles in R&D and then latterly held a commercial role where he managed a £20m product portfolio. In 2005 he joined Isis Innovation Ltd, where he initiated, led and concluded a range of multi-£m transactions. In 2008 he went on to recruit and direct a Business Development team that managed over 200 medical science innovations emanating from Oxford University. In 2011 he joined OrganOx Ltd as Operations Director where he handled all operational and contractual aspects of the business that saw the company take a class III medical device from prototype into, and successfully through, first in man clinical trials. In January 2014 he became Co-Founder, Executive Director and the Chief Executive Officer of OxSonics® Ltd.
Follow Colin Story:
About OrthoSon, OxSonics Therapeutics: OxSonics® Therapeutics’ proprietary drug delivery platform technology, SonoTran®
Harry Destecroix
Founder and CEO of Ziylo
Follow Harry Destecroix:
About Ziylo: Ziylo has developed Biomimetic Glucose Binding Molecules (GBM) for Continuous Glucose Monitors (CGM) & Glucose Responsive Insulins (GRI)
George Frodsham
Founder & CEO of MediSieve
George Frodsham founded MediSieve after being awarded his PhD in biochemical engineering from University College London (UCL), during which he developed the magnetic blood filter. As well as being a physicist and engineer, George is an entrepreneur. George was awarded a BBSRC Enterprise Fellowship from the Royal Society of Edinburgh in 2014. Since 1996, only 180 individuals have benefited from this highly competitive and prestigious programme. George has also completed the Entrepreneurship Summer School programme at the London Business School. This equipped him to research target markets and industries and turn his visions into viable businesses.
Follow George Frodsham:
About MediSieve: MediSieve is a therapeutics company developing a platform technology for the treatment of blood-borne diseases.
James Carroll
Co-Founder of LumiThera
James Carroll is Founder & CEO of THOR Photomedicine and an acknowledged world expert on the effect of light on cellular function. James’ role is to develop the best possible light parameters for maximizing the effects from a wearable device.
Follow James Carroll:
About LumiThera, The Quantlet, THOR Photomedicine: LumiThera is a medical device company focused on LED and laser treatments for acute and chronic ocular disease.
Gemma Timms
Founder & COO of VitaeVR
Gemma Timms is an executive at Hakluyt and the co-founder of Vitae VR.
Follow Gemma Timms:
About VitaeVR: Medical devices for early diagnosis of cognitive disease
Duncan McWilliam
Founder & CEO of VitaeVR
Duncan McWilliam is the founder and CEO of VitaeVR and Outpost VFX.
Follow Duncan McWilliam:
About VitaeVR: Medical devices for early diagnosis of cognitive disease
Kitty Liao
Founder & CEO of Ideabatic
Royal Academy of Engineering 2018 Enterprise Fellow, Ambassador at THE Port Association, Switzerland. Ten years experience in multi-disciplinary system design and R&D, including low temperature systems, superconducting cavity diagnostics systems and design for low-resource settings.
Follow Kitty Liao:
About Ideabatic: Ideabatic is solving the most challenging humanitarian problems by delivering innovative solutions and devices.
Jordan Van Flute
Co-Founder & CTO of Inovus Medical
Jordan is is a psychology graduate from Cardiff University. His main roll is head of the design and manufacturing team, the area in which he is the most passionate. It is his original research into psychomotor testing and laparoscopic surgery, which provided the fundamental ideas for the first Pyxus laparoscopic simulator.
Follow Jordan Van Flute:
About Inovus Medical: The perfect package for any general surgical trainees or residents.
Edward Ridyard
Co-Founder of Inovus Medical
Edward studied medicine at the University of Manchester. He played a crucial role in the early conception of the Pyxus laparoscopic simulator, liaising with surgeons and surgical trainees in order to develop a customer centred product. Although still important to the Inovus team, he has taken a step back from daily operations in order to pursue a career in surgery.
Follow Edward Ridyard:
About Inovus Medical: The perfect package for any general surgical trainees or residents.
Elliot Street
Co-Founder & CEO of Inovus Medical
Elliot studied medicine at the University of Manchester before completing his foundation training at the Oxford University Hospitals. Alongside his clinical commitments, he retains an active role in product development, bridging the gap between clinician and designer as well as running Inovus’ sales and marketing operations.
Follow Elliot Street:
About Inovus Medical, NHS England: The perfect package for any general surgical trainees or residents.
Faii Ong
Founder and CEO of GyroGear
Faii Ong is the founder and CEO of GyroGear.
Follow Faii Ong:
About GyroGear: GyroGear is developing a wearable to help individuals with hand tremors.
Lise Pape
Founder of Walk With Path
Lise is the Founder of Walk With Path and the inventor of the two products. She holds a double Masters in Innovation Design Engineering from the Royal College of Art and Imperial College London. Prior to that, she worked for Invest in Denmark at the Royal Danish Embassy in London, where she was responsible for attracting foreign companies to Denmark within the sectors of life sciences and clean technologies. She has also worked in online advertising for AOL’s Advertising.com and in finance for J.P. Morgan. Lise holds a BSc in Human Biology from King’s College London.
Follow Lise Pape:
About Future Care Capital, Walk With Path, Walk With Path: Walk With Path is a mobility company providing active wearables and data insights to improve human function.
Nick Skaer
Founder and CEO of Orthox Ltd.
Nick Skaer has over 20 years experience in life science and materials research, and 10 years as a medtech CEO raising over £10m to fund development of FibroFix™ technology. In 2008 he founded Orthox with Prof. Oliver Kessler, securing a Translation Award from Wellcome Trust. Since then he has led the scientific and commercial programmes at Orthox, with further awards from the Technology Strategy Board, Wellcome Trust, and NIHR. Before this he was CSO, then CEO of Oxford Biomaterials from 2004 to 2009 where he developed the FibroFix™ technology and implemented the medical device programme. During this period he co-authored 5 patents, including the three assigned to Orthox, secured over £2 million in public grants and private investment and formed 3 spin out companies from Oxford Biomaterials to commercialise biomaterial technologies. Between 1992 and 2003 he studied Molecular Biology at the Universities of Oxford, Cambridge and Strasbourg France, where he obtained his PhD.
Follow Nick Skaer:
About Orthox Ltd.: Orthox develops tissue regenerative implants that address large injuries to cartilage tissues in which early osteoarthritis may be present.
Oliver Kessler
Founder, Medical Director and Chief Medical Officer of Orthox Ltd.
Oliver Kessler is a practising knee surgeon based in Zurich with a strong track record of biomaterials research and a focus on meniscal and cartilage repair systems and joint kinematics. He spent 6 years at Stryker Orthopaedics as Director of Orthobiologics supervising a major meniscal tissue engineering programme. He has extensive contacts within both the orthopaedic industry and the surgical community and is responsible for overseeing clinical development of Orthox’s product pipeline.
Follow Oliver Kessler:
About Orthox Ltd.: Orthox develops tissue regenerative implants that address large injuries to cartilage tissues in which early osteoarthritis may be present.
Andrew Newell
Managing Director & Founder of Cipher Surgical
Andrew Newell is Founder & Managing Director at Cipher Surgical
Follow Andrew Newell:
About Cipher Surgical, Exomedica: Cipher Surgical is a medical device company established to design, patent, and globally market its laparoscopic medical device.
Charalambos Antoniades
Founder and Chief Scientific Officer of Caristo Diagnostics
Follow Charalambos Antoniades:
About Caristo Diagnostics: Caristo Diagnostics utilises standard CT scans to identify potentially heart-stopping plaques
Neel Patel
Founder & Chief Executive Officer of ZiO Health
Follow Neel Patel:
About ZiO Health: ZiO Health has developed proprietary pocket-sized technology, bringing lab testing to the point of use.
Alex Papanikolaou
Founder and Technical Director of Freedom One Life
Born with Athetoid cerebral palsy, from a young age, I have been determined that whatever physical difference I have, it isn’t going to stop me from living and experiencing life in the way that I want, and from doing the things I want to do in the way that I want to do them. My experiences and insights have led me to starting Freedom One Life, to inspire and empower people living with a physical disability. Enabling people around the world to expect and demand the same standard of living and mobility that a non-disabled person takes for granted. The first product is a game changing next generation power wheelchair. I have worked in national retail stores, driven around the country and travelled around the world with my power wheelchair. I have consulted internationally on access, equality, inclusiveness and I’ve been part of progressive change towards creating more inclusive environments.
Follow Alex Papanikolaou:
About Freedom One Life: Redefining mobility
Samantha Perona
CEO, Founder & Director of Perfectus Biomed
Experienced Chief Executive Officer, PhD, MSC with a demonstrated history of working in commercial research. Skilled in Good Laboratory Practice (GLP), ISO 9001 and 17025. Experience with FDA 510K data generation and MDD/MDR compliance. Strong business development professional with a Goldman Sachs 10,000 small businesses focused in Business.
Follow Samantha Perona:
About Perfectus Biomed: Perfectus Biomed is a U.K.-based biotechnology company providing microbiological services.
Herbert Oakes
Founder & CEO of NOXSUDOR THERAPEUTICS LIMITED
Herbert Oakes, non-executive director, is an investment banker and builder of high technology life sciences companies. He is currently a Managing Director of Oakes, Lyman & Co. Limited an investment banking firm specialising in high-tech healthcare; a Managing director of Hycroft Advisors, a global investment banking firm specialising in arranging capital for private equity partnerships; and CEO of NoxSudor Therapeutics Limited, a start-up medical business developing a therapy for hot flashes and night sweats for menopausal women. He is an advisor of Wilton Corporate Finance Limited.
Follow Herbert Oakes:
About NOXSUDOR THERAPEUTICS LIMITED: First prescription medical device to control sweating
Toby Basey-Fisher
Co-Founder & CEO of Entia
Toby Basey-Fisher serves as a Co-Founder & CEO at Entia.
Follow Toby Basey-Fisher:
About Entia, Imperial College London: Entia is a medical technology company that specializes in improving access to blood test.
Stephen Dunniece
CTO & Founder of Cirdan
A founder of Cirdan, Stephen studied at Belfast Institute and the University of Ulster where he completed a MSc. in Electronics and Signal Processing. After working in the Physics Dept at QUB he joined Belfast start-up Andor Technology Ltd. For the next 7 years, he undertook all aspects of camera hardware design. In 1999, Stephen became Director of his own business, Audio Control Systems Ltd, involved in the design and installation of interactive equipment for the special needs sector.
Follow Stephen Dunniece:
About Cirdan: Cirdan delivers solutions that enable rapid implementation of a robust and scalable digital pathology workflow into a laboratory.
Tim Oakes
CTO and Co-Founder of ViCentra
From a young age, Tim could usually be found surrounded by tools and prototypes, building his own boats and rigging elaborate zip lines in his garden. Now an award-winning design engineer, Tim has over seven years’ experience in the medical device field, working on projects as diverse as drug delivery platforms to laparoscopic surgical instruments. Having grown up with a father with Type 1 diabetes, Tim has first-hand knowledge of the challenges of trying to incorporate complex medical devices into daily life and is driven by a deep desire to create products that help make life easier.
Follow Tim Oakes:
About ViCentra: ViCentra has developed an insulin pump for diabetes patients.
Cameron Shaw
Founder and COO of Virax Biolabs
Cameron Shaw is the founder and Chief Operations Officer at Virax Biolabs.
Follow Cameron Shaw:
About Virax Biolabs: Virax Biolabs is an innovative Biotechnology company focused on the prevention, detection and diagnosis of viral diseases
Oriane Chausiaux
Founder Director – CSO, Serial Entrepreneur of Heartfelt Technologies
Follow Oriane Chausiaux:
About Heartfelt Technologies: Heartfelt Technologies are developing the only home-based heart failure monitor that does not require patient interaction or compliance.
Gary Gibson
Founder & Board Member of Ibex Innovations
Gary is the founder of IBEX Innovations, which he formed in 2010. He developed the fundamental technology behind IBEX and then successfully obtained venture capital backing for the company in 2012. Gary stepped down as CEO in 2013, moving into his current role as Chief Scientific Officer. He also takes management responsibility for the IBEX quality systems. Gary graduated with a PhD from Imperial College, London, in 1999, and then took up a research post at the University of Cambridge. After being offered a fellowship at Cambridge, he moved into research positions in high tech industries, working for a number of blue chip corporations, such as SDL and JDSU, and start-ups such as Intense Photonics. He headed many different research teams but then became fascinated with the interplay between commerce and technology. He shifted his focus to sales and marketing and account management, being promoted to become Deputy Director of Sales and Marketing at Bede X-Ray Metrology, a successful X-ray technology company based in Durham. Gary worked for Kromek for a number of years as a product manager and then Phase Focus, a high-tech start-up in microscopy, as Director of Sales and Marketing.
Follow Gary Gibson:
About Dyman Advanced Materials, Ibex Innovations: IBEX X-ray detector technology adds materials information to silicon based detectors.
Richard Mcconnell
Co-Founder & COO of Liopa
Follow Richard Mcconnell:
About Anaeko, Liopa: Liopa’s LipRead deciphers speech from lip movements. It uses AI and deep learning for automated lip reading.
Guang Zhong Yang
Co-Founder of Smart Surgical Appliances
Guang-Zhong Yang is Founder of Smart Surgical Appliances Limited. Guang-Zhong Yang serves at Institute of Biomedical Engineering.
Follow Guang Zhong Yang:
About Smart Surgical Appliances: Smart Surgical Appliances is a medical device company, developing sensor-enabled surgical instrumentation.
Ara Darzi
Co-Founder of Smart Surgical Appliances
Prof. Ara Darzi, KBE MD, FRCS, FRCSI, FACS, co-founded SynaptiQ Ltd. in 2001. Prof. Darzi is the Founder of Smart Surgical Appliances Limited. He serves as the Head of Scientific Advisory Board, Director and Member of Scientific Advisory Board of SynaptiQ Ltd. He served as a Hunterian Professor of the Royal College of Surgeons of England. He holds the Chair of Surgery at Imperial College School of Medicine and is also the Tutor in Minimal Access Surgery at the Royal College of Surgeons in England. He is the James IV traveling fellow for 1999/2000, and is also a Council Member of the Association of Coloproctologists of Great Britain and Ireland, The Association of Endoscopic Surgeons of Great Britain and Ireland, and the Society of Minimal Invasive Therapy. He is also the Chairman of the London Committee for the Modernisation of the National Health Service, which is charged with recommending how best to modernise the NHS. He was appointed as Advisor on Surgery to the Department of Health. He serves as Vice Chairperson at Sidra Medical and Research Centre. He conferred a Fellow of the American College of Surgeons. His main clinical and academic interest is Minimal Invasive Therapy, including Imaging and Biological research. He has co-authored over 100 peer review publications and five books on surgery. Prof. Darzi received an honorary Knighthood in December 2002 in recognition of his service to the United Kingdom National Health Service. Prof. Darzi obtained his fellowship in Surgery from the Royal College of Surgeons in Ireland and an M.D. degree from Trinity College, Dublin.
Follow Ara Darzi:
About Smart Surgical Appliances, The Institute of Cancer Research: Smart Surgical Appliances is a medical device company, developing sensor-enabled surgical instrumentation.
Anurag Agarwal
Founder of The Cambridge Stethoscope Company
Follow Anurag Agarwal:
About The Cambridge Stethoscope Company: The Cambridge Stethoscope Company is developing the world’s first intelligent stethoscope that is capable of automated diagnosis.
Charles Ball
Co-Founder and Commercial Manager of Chronomics
Charles Ball is the Co-Founder and Commercial Manager at Chronomics.
Follow Charles Ball:
About Chronomics: Tech-bio company, providing access to a ‘bio-infrastructure’ to simplify and speed-up the use of biomarkers to improve everyday decisions.
Toby Call
Co-Founder of Chronomics
Toby Call is the Co-Founder of Chronomics.
Follow Toby Call:
About Chronomics: Tech-bio company, providing access to a ‘bio-infrastructure’ to simplify and speed-up the use of biomarkers to improve everyday decisions.
Daniel Elías Martín Herranz
Co-Founder and CSO of Chronomics
Daniel Elías Martín Herranz is the Co-Founder and CSO at Chronomics.
Follow Daniel Elías Martín Herranz:
About Chronomics: Tech-bio company, providing access to a ‘bio-infrastructure’ to simplify and speed-up the use of biomarkers to improve everyday decisions.
Neciah Dorh
Co-Founder and CEO of FluoretiQ
Neciah Dorh is a Co-Founder and serves as the Chief Executive Officer at FluoretiQ.
Follow Neciah Dorh:
About FluoretiQ: FluoretiQ is a medical device company designing simple and effective bacterial detection systems for rapid diagnosis of infection.
Andrew Hall-Ponselè
Founder and Director of Operations of Biotangents
Andy designed the Leapfrog Assembly™ technology upon which Biotangents was founded and led the successful project to apply it to the biosynthesis of high-value terpenoids. He now leads operations at Biotangents and is part of an ambitious team that has secured and fulfilled multiple contracts to perform DNA manipulation work for industrial and academic customers. Andy has been involved in synthetic biology since 2008 when, as a student under Professor Chris French, he led the University of Edinburgh iGEM team to a gold medal. He holds a DPhil from the University of Oxford, where he used metabolic engineering approaches to provide new insights into the control of metabolism in plants. On his return to Edinburgh, Andy worked as a Senior Scientist in a University of Edinburgh-based start-up, delivering collaborative projects as varied as synthetic promoter design and polysaccharide biosynthesis.
Follow Andrew Hall-Ponselè:
About Biotangents: Biotangents develop pen-side diagnostic devices to detect infectious diseases in livestock quickly.
Lina Gasiūnaitė
Founder and Director of Science of Biotangents
As the Director of Science at Biotangents, Lina is leading delivery of Moduleic Sensing™ for the diagnosis of infectious diseases in livestock. Lina completed her undergraduate studies in Molecular Biology at Vilnius University and holds an MSc in Biotechnology from the University of Edinburgh. As part of her dissertation, she incorporated standardisation into a proprietary combinatorial DNA assembly technology, making it compatible with the widely used BioBrick™ standard. Lina also acted as an advisor to the University of Edinburgh’s 2013 gold medal-winning iGEM team. After graduation, Lina continued to work in DNA manipulation and metabolic engineering of bacteria, delivering varied projects with local SMEs and multinational partners.
Follow Lina Gasiūnaitė:
About Biotangents: Biotangents develop pen-side diagnostic devices to detect infectious diseases in livestock quickly.
Matthew Robson
Founder & Chief Technology Officer of Perspectum
Matt Robson is Perspectum’s Chief Technical Officer (CTO), co-founder and company director. He is responsible for overseeing development and implementation of our image acquisition and image analysis pipelines. Matt has over 25 years of experience working with MRI initially through his PhD at Cambridge in “Automated Analysis of MRI Images” that followed from a Natural Science (Physics and Theoretical Physics) also in Cambridge. He followed this with Research positions at Yale University and industrial roles with GEC, Surrey Medical Systems, Picker International and Marconi Medical before returning to academia with Oxford University where he pioneered the technologies that underpin Perspectum’s products.
Follow Matthew Robson:
About Perspectum: Healthcare, Medical Technology, SaaS
Rajarshi Banerjee
Chief Executive Officer & Founder of Perspectum
Rajarshi Banerjee is CEO of Perspectum, which he co-founded in 2012, and now employs over 100 people in Oxford, Singapore and San Francisco. Rajarshi has worked in the National Health Service since 2002, and trained in cardiology and internal medicine in London and Oxford. He developed the MR techniques for rapid non-invasive liver assessment in Oxford, and commercialized the method as LiverMultiScan, which is now FDA cleared and used in over 200 sites. He graduated in medicine from Oxford, and went on to complete a Masters in Public Health in London before returning to Oxford for his doctorate. Dr Banerjee continues to work as a Consultant Physician with Oxford University Hospitals NHS Foundation Trust, with research into the phenotyping of liver disease at an individual and population level in adults and children. He has many years of experience in running clinical trials and working in multidisciplinary scientific teams to develop applications for cutting-edge imaging technology and is a keen advocate of smart trial design.
Follow Rajarshi Banerjee:
About Perspectum: Healthcare, Medical Technology, SaaS
Jon Holmes
Co-Founder and CEO of Michelson Diagnostics
Under Jon’s skilful and visionary leadership, Michelson Diagnostics Ltd has rapidly grown from a fledgling start-up in 2006, to the thriving company it is today. He has masterminded five rounds of investment, and his strategy for growth has enabled the company to achieve all of its milestones to date, on time and on budget.Jon was previously Business Director of the Biomedical Group at Sira, the instrumentation R&D company, and was Director of the Smart Optics Faraday Partnership.
Follow Jon Holmes:
About Michelson Diagnostics, Michelson Diagnostics, SmartOptics: Michelson Diagnostics develops and manufactures multi-beam Optical Coherence Tomography-based products.
Charles Large
Founder and CEO of Autifony Therapeutics
Charles Large received his first degree and PhD from the University of Bristol and has more than 20 years of experience of drug discovery and development in the pharmaceutical industry. Before founding Autifony, he was Director of Molecular and Cellular Biology within the Neuroscience Centre of Excellence for Drug Discovery at GlaxoSmithKline, and has worked on programs focused on schizophrenia, Alzheimer’s disease, epilepsy, bipolar disorder, and major depression. He is an expert on drugs that modulate voltage gated ion channels and their application to neurological and psychiatric disorders. He has built up a reputation in the field of sodium channel blocking drugs, and has collaborated widely with academic groups. He has authored over 50 papers, book chapters and patents relating to ion channel modulators.
Follow Charles Large:
About Autifony Therapeutics: Autifony Therapeutics is a biotechnology company developing medicines to treat hearing disorders such as hearing loss and tinnitus.
Billy Boyle
CEO and Co-Founder of Owlstone Nanotech
Since co-founding Owlstone, Billy has been overseeing the development and implementation of the detection technology with nanotechnology foundry partners. He is also active in business development, demonstrating to partners how the Owlstone technology can used to realise a paradigm shift in detection applications and deployment scenarios. Billy is heavily involved in the creation and realisation of new technologies and IP. Prior to joining Owlstone Billy was a Research Associate in the Microsystems and Nanotech group at Cambridge University. In an academic / industry consortium he designed and developed silicon-opto hybrid devices for next generation telecoms systems.
Follow Billy Boyle:
About Owlstone Nanotech: OWLSTONE is a platform technology, where regardless of the application, hardware remains the same & the app is enabled through software.
Kosta Mavroulakis
Founder and CEO of Empact Ventures
Follow Kosta Mavroulakis:
About Empact Ventures: Empact Ventures co-designs some of the leading startup, tech and non-profit initiatives for large private or public sector organisations
Alan Preece
Founder & Consultant of Micrima
Currently Emeritus Professor in the Department of Medical Physics at the University of Bristol and honorary Consultant Clinical Scientist with the United Bristol Healthcare Trust (UBHT). Previously Head of Biophysics Unit, Department of Medical Physics and Professor of Medical Physics, University of Bristol. Alan is a board member of the Bioelectromagnetics Society (USA) and the European Bioelectromagnetics Society, a Fellow of the Institute of Physics and Engineering in Medicine. He has delivered numerous invited lectures worldwide and has received numerous prizes for his work.
Follow Alan Preece:
About Micrima, United Bristol Healthcare Trust, University of Bristol: Developing a breast imaging system using no ionising radiation, no breast compression and good in dense breasts. All issues for currently.
Rafael Michaeli
CoFounder of SAVA
Follow Rafael Michaeli:
About SAVA: The first effortless continuous molecular tracker unlocking human perfomance
Mel Vinton
Chief Technology Officer & Co-Founder of Inotec AMD
Mel Vinton is a Chief Technology Officer & Co-Founder at Inotec AMD.
Follow Mel Vinton:
About Inotec AMD: Inotec AMD is a medical device company.
Daniel Crawford
Founder of Axial3D
Daniel Crawford is Founder at axial3D.
Follow Daniel Crawford:
About Axial3D: Axial3D is 3D printing anatomical models for the healthcare industry.
Sean Pollock
Founder & COO of Opus Medical
Doctor Sean Pollock researched and developed the Breathe Well technology over 5 years for his Masters and PhD in medical physics, transitioning into a full time role in the company after the completion of his PhD.
Follow Sean Pollock:
About Opus Medical: Opus Medical designs and manufactures medical devices for use in motion management during cancer treatment.
Hugo Macedo
CEO & Founder of Smart Separations Ltd
Hugo is the founder and CEO of Smart Separations Ltd. He has over 11 years of experience in entrepreneurship which helped him founding this start-up company that has developed a proprietary filter that can be tailored to suit many different applications in the poorly explored but very large microfiltration market, from biotechnology to food & drink processing. Throughout his PhD in Biomedical Engineering, Hugo was constantly challenged with new and diverse tasks, in a multidisciplinary environment, where he breathed skills from chemical engineering to stem cell technology, including membrane technology, hydrodynamics, stem cell culture and bioprocessing, human blood production, amongst many others. This provided him with the right tools to create the first “3D hollow fibre bioreactor for the production of human red blood cells” – a system design that he patented. This work was featured in different magazines, including the cover page of The Chemical Engineer (TCE) in 2011, selected as one of “Ten life-changing ideas under research at UK universities” by the Research Councils UK and shortlisted for the highly prestigious IChemE Awards in 2011. Hugo currently holds 2 patents and is passionate for innovation leading to improve people’s quality of life – a vision that he has shared with Smart Separation
Follow Hugo Macedo:
About Smart Separations Ltd: Smart Separations is a limited company based in London UK that has patented an innovative microfiltration technology.
Andrew Morgan
Co-Founder of Exyo
Follow Andrew Morgan:
About Exyo: Exyo design novel, life enhancing medical devices such as posture walkers, making outdoor activities accessible.
Pawel de Sternberg Stojalowski
Managing Director & Founder of Aseptium
Company was originated out of Pawel’s passion for clever solutions as he is a design engineer, first and foremost. Thanks to his background in mechanical engineering (MSc 2006), automation and robotics (BSc 2006) as well as business (MBA 2013) he takes an interdisciplinary approach to projects, integrating both engineering and commercial aspects. Decontamination of surgical instruments combines many disciplines of science and that is what brought Pawel into this environment. Complexity as well as multitude of problems require creativity and a wide spectrum of knowledge in order to devise innovative solutions. Pawel was involved in R&D of surgical instruments reprocessing equipment since 2007. In that time he contributed to over 100 products that reached the market – from ultrasonic washers through pass-through washer disinfectors to sterilisation indicators. Today his main focus is on complex surgical instruments and challenges industry faces reprocessing them.
Follow Pawel de Sternberg Stojalowski:
About Aseptium: Aseptium provides innovative decontamination solutions that reduce infections carried by dirty surgical instruments.
Sam Ford
Co-Founder and Managing Director of Tap2Tag
Follow Sam Ford:
About Tap2Tag: Tap2Tag is seeking further investment for expansion plans into overseas markets.
Yen Choo
Founder of Plasticell
Yen Choo is a Founder at Plasticell.
Follow Yen Choo:
About Plasticell: Plasticell offers a cell-based screening technology for the discovery of small molecule drugs that regenerate cells of the body.
Sukhbinder Noorpuri
Founder & CEO of i-GP
With over 15 years of NHS experience, Dr Noorpuri founded i-GP to improve patient access to care that is convenient, affordable and safe.
Follow Sukhbinder Noorpuri:
About i-GP: i-GP is an online service that provides customers with medical services and advice.
Tariq Aslam
Founder of Clin-e-cal
Follow Tariq Aslam:
About Clin-e-cal: Clin-e-cal is a digital health company,
Malav Sanghavi
Founder and Director of Creoto Technologies
Follow Malav Sanghavi:
About Creoto Technologies: Creoto Technologies is developing the first custom fitting, standardised, smart prosthetic socket.
David Goodwin
Founder of Flexyfoot
Follow David Goodwin:
About Flexyfoot: For anyone who needs a walking stick, walking cane or crutches to get around.
David Goodwin
Founder of Flexyfoot
Follow David Goodwin:
About Flexyfoot: For anyone who needs a walking stick, walking cane or crutches to get around.
